Residency · Philadelphia, PA
Sponsored by SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
The Lancet. Oncology · 2021 · 402 citations · Leonard Gomella
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet (London, England) · 2022 · 224 citations · Leonard Gomella
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
NEJM evidence · 2023 · 165 citations · Edouard Trabulsi
Comparison of ChatGPT and Traditional Patient Education Materials for Men's Health.
Urology practice · 2024 · 45 citations · Costas Lallas, Mihir Shah
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 50 citations · Edouard Trabulsi
Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part I: Evaluation and Treatment of Patients With Kidney and/or Ureteral Stones.
The Journal of urology · 2026 · 15 citations · Kymora Scotland
Development and internal validation of a nomogram predicting 3-year chronic kidney disease upstaging following robot-assisted partial nephrectomy.
International urology and nephrology · 2024 · 37 citations · Daniel Eun
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
The Journal of urology · 2024 · 81 citations · Leonard Gomella